0 Items
Toll Free (US) - +1-866-598-1553
sales@precisionbusinessinsights.com
Infectious Disease Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

Infectious Disease Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00 – $ 8,900.00

Infectious Disease Diagnostics Market by Product Type (Assays, Kits, & Reagents, Instruments, Services & Software), Testing Type (Laboratory Testing, POC Testing), Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, Others), Disease Type (COVID-19, HIV, HAIs, Hepatitis, STDs, HPV, TB, Influenza, Others), End User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Others) and Geography

Request Sample Request Methodology
Request Sample Read More
$ PRICE - $ 3,000.00 – $ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00 – $ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,
Report

Description

Infectious Disease Diagnostics Market size is expected to be worth USD 34,599.0 million in 2020, growing at a high CAGR of 6.4% from 2022 to 2028 to reach USD 50,201.2 million by 2028. The market for infectious disease diagnostics is fueled by increased infectious disease prevalence, a shift in focus from centralized laboratories to decentralized point-of-care testing, and Infectious Disease Research Diagnostics, increased prevalence of infectious disease, increased number of medical laboratories for infectious disease diagnostic testing, increased demand for point-of-care diagnostic tests, increased funding from private and government organizations for diagnostic service centers, and advancements in infectious disease diagnostic technologies. Infectious diseases are illnesses brought on by bacteria, viruses, fungi, or parasites. In most cases, they’re innocuous or even beneficial. However, some microbes can cause sickness under particular circumstances. Some infectious diseases are contagious and can be spread from one person to the next. The technique by which the causative agent of an infectious disease is discovered and often defined is known as infectious-disease diagnostics. However, inadequate reimbursements and rising healthcare costs limiting the use of novel diagnostic techniques hampers the Infectious Disease Diagnostics market.

Key Developments:

In February 2021, Thermo Fisher Scientific acquired Mesa Biotech (US) to expand the benefits of molecular diagnostics at the point of care.

Infectious Disease Diagnostics Market

MARKET SUMMARY
-
6.4% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 6.4%
  • Largest Market– Asia Pacific
  • Fastest Growing Market–  North America

Infectious Disease Diagnostics Market

  • The infectious disease diagnostics market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The infectious disease diagnostics market is segmented based on based on product, type of testing, technology, disease, end user, and geography.
Market Key Players
  • Abbott Laboratories
  • Becton Dickinson and Company
  • bioMerieus SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F Hoffman-La Roche
Infectious Disease Diagnostics Market Dynamics

The infectious Disease Diagnostics market is surging owing to frequent acquisitions and launchings by the market players. Strategic alliances by the players, such as acquisitions, mergers, expansions, and new product launches, may enhance the company’s growth. For instance, In March 2021, Roche Diagnostics Launched Cobas SARS-CoV-2 Variant Set 1 Test to help monitor emerging coronavirus mutations.

North-America Got Significant Share

Infectious Disease Diagnostics Market

North America is predicted to have the largest share of the Infectious Disease Diagnostics market by 2028, and it is expected to grow rapidly in the following years. The development of infectious disease diagnostics is driven by the presence of key players, the development of the healthcare sector, the presence of national clinical laboratories, and the advancement in technology for diagnostic instruments in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share and forecast from 2021-2027
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Infectious Disease Diagnostics Market Segmentation

segmentation-block-image

Product- Testing

    • Assays, Kits, & Reagents
    • Instruments
    • Services & Software
    • Laboratory Testing
    • POC Testing
segmentation-block-image

Technology

    • Immunodiagnostics
    • Clinical Microbiology
    • PCR
    • INAAT
    • DNA Sequencing & NGS
    • Others
segmentation-block-image

Disease Type

    • COVID-19
    • HIV
    • HAIs
    • Hepatitis
    • STDs
    • HPV
    • TB
    • Influenza
    • Others
segmentation-block-image

End User

    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Academic Research Institutes
    • Others
Location

GEOGRAPHY

Frequently Asked Questions

The infectious disease diagnostics market is projected to expand at a CAGR of 6.4% during the forecast period.

Abbott Laboratories, Becton Dickinson and Company, bioMerieus SA, Bio-Rad Laboratories, Danaher Corporation, F Hoffman-La Roche

North America is the fastest-growing region for infectious disease diagnostics market

Report

Table Of Content

1. Executive Summary
2. Global Infectious Disease Diagnostics Market Introduction
2.1. Global Infectious Disease Diagnostics Market – Taxonomy
2.2. Global Infectious Disease Diagnostics Market –Definitions
2.2.1. Product Type
2.2.2. Testing Type
2.2.3. Technology
2.2.4. Disease Type
2.2.5. End User
3. Global Infectious Disease Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Infectious Disease Diagnostics Market Dynamic Factors – Impact Analysis
3.6. Global Infectious Disease Diagnostics Market – Competition Landscape
4. Global Infectious Disease Diagnostics Market Analysis,2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Infectious Disease Diagnostics Market, By Product Type, 2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
5.1. Assays, Kits, & Reagents
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Services & Software
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Infectious Disease Diagnostics Market, By Testing Type, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Laboratory Testing
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. POC Testing
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Infectious Disease Diagnostics Market Forecast, By Technology,2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
7.1. Immunodiagnostics
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Clinical Microbiology
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. PCR
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. INAAT
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. DNA Sequencing & NGS
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Infectious Disease Diagnostics Market Forecast, By Disease Type, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
8.1. COVID-19
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. HIV
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. HAIs
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Hepatitis
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. STDs
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. HPV
8.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.6.3. Market Opportunity Analysis
8.7. TB
8.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.7.3. Market Opportunity Analysis
8.8. Influenza
8.8.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.8.3. Market Opportunity Analysis
8.9. Others
8.9.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.9.3. Market Opportunity Analysis
9. Global Infectious Disease Diagnostics Market, By End User, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
9.1. Diagnostic Laboratories
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Hospitals & Clinics
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Academic Research Institutes
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Others
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
10. Global Infectious Disease Diagnostics Market Forecast, By Region, 2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
10.1. North America
10.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Region, 2022 – 2028
11. North America Infectious Disease Diagnostics MarketAnalysis,2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
11.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Assays, Kits, & Reagents
11.1.2. Instruments
11.1.3. Services & Software
11.2. Testing Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Laboratory Testing
11.2.2. POC Testing
11.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Immunodiagnostics
11.3.2. Clinical Microbiology
11.3.3. PCR
11.3.4. INAAT
11.3.5. DNA Sequencing & NGS
11.3.6. Others
11.4. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. COVID-19
11.4.2. HIV
11.4.3. HAIs
11.4.4. Hepatitis
11.4.5. STDs
11.4.6. HPV
11.4.7. TB
11.4.8. Influenza
11.4.9. Others
11.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Diagnostic Laboratories
11.5.2. Hospitals & Clinics
11.5.3. Academic Research Institutes
11.5.4. Others
11.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.6.1. USA
11.6.2. Canada
11.7. North America Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country, 2022 – 2028
11.8. North America Infectious Disease Diagnostics Market Dynamics – Trends
12. Europe Infectious Disease Diagnostics Market Analysis, 2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
12.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Assays, Kits, & Reagents
12.1.2. Instruments
12.1.3. Services & Software
12.2. Testing Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Laboratory Testing
12.2.2. POC Testing
12.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Immunodiagnostics
12.3.2. Clinical Microbiology
12.3.3. PCR
12.3.4. INAAT
12.3.5. DNA Sequencing & NGS
12.3.6. Others
12.4. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. COVID-19
12.4.2. HIV
12.4.3. HAIs
12.4.4. Hepatitis
12.4.5. STDs
12.4.6. HPV
12.4.7. TB
12.4.8. Influenza
12.4.9. Others
12.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.5.1. Diagnostic Laboratories
12.5.2. Hospitals & Clinics
12.5.3. Academic Research Institutes
12.5.4. Others
12.6. Country Analysis 2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Russia
12.6.7. Poland
12.6.8. Rest of Europe
12.7. Europe Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End Userand Country, 2022 – 2028
12.8. Europe Infectious Disease Diagnostics Market Dynamics – Trends
13. Asia-Pacific Infectious Disease Diagnostics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Assays, Kits, & Reagents
13.1.2. Instruments
13.1.3. Services & Software
13.2. Testing Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Laboratory Testing
13.2.2. POC Testing
13.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Immunodiagnostics
13.3.2. Clinical Microbiology
13.3.3. PCR
13.3.4. INAAT
13.3.5. DNA Sequencing & NGS
13.3.6. Others
13.4. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. COVID-19
13.4.2. HIV
13.4.3. HAIs
13.4.4. Hepatitis
13.4.5. STDs
13.4.6. HPV
13.4.7. TB
13.4.8. Influenza
13.4.9. Others
13.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Diagnostic Laboratories
13.5.2. Hospitals & Clinics
13.5.3. Academic Research Institutes
13.5.4. Others
13.6. Country Analysis2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. ASEAN
13.6.5. Australia & New Zealand
13.6.6. Rest of Asia-Pacific
13.7. Asia-Pacific Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country,2022 – 2028
13.8. Asia-Pacific Infectious Disease Diagnostics Market Dynamics – Trends
14. Latin America Infectious Disease Diagnostics Market Analysis,2017 – 2021 and Forecast, 2022–2028(Revenue, USD Mn)
14.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
14.1.1. Assays, Kits, & Reagents
14.1.2. Instruments
14.1.3. Services & Software
14.2. Testing Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Laboratory Testing
14.2.2. POC Testing
14.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Immunodiagnostics
14.3.2. Clinical Microbiology
14.3.3. PCR
14.3.4. INAAT
14.3.5. DNA Sequencing & NGS
14.3.6. Others
14.4. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. COVID-19
14.4.2. HIV
14.4.3. HAIs
14.4.4. Hepatitis
14.4.5. STDs
14.4.6. HPV
14.4.7. TB
14.4.8. Influenza
14.4.9. Others
14.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.5.1. Diagnostic Laboratories
14.5.2. Hospitals & Clinics
14.5.3. Academic Research Institutes
14.5.4. Others
14.6. Country Analysis 2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Argentina
14.6.4. Rest of Latin America
14.7. Latin America Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country, 2022 – 2028
14.8. Latin America Infectious Disease Diagnostics Market Dynamics – Trends
15. Middle East and Africa Infectious Disease Diagnostics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
15.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
15.1.1. Assays, Kits, & Reagents
15.1.2. Instruments
15.1.3. Services & Software
15.2. Testing Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.2.1. Laboratory Testing
15.2.2. POC Testing
15.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Immunodiagnostics
15.3.2. Clinical Microbiology
15.3.3. PCR
15.3.4. INAAT
15.3.5. DNA Sequencing & NGS
15.3.6. Others
15.4. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.4.1. COVID-19
15.4.2. HIV
15.4.3. HAIs
15.4.4. Hepatitis
15.4.5. STDs
15.4.6. HPV
15.4.7. TB
15.4.8. Influenza
15.4.9. Others
15.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.5.1. Diagnostic Laboratories
15.5.2. Hospitals & Clinics
15.5.3. Academic Research Institutes
15.5.4. Others
15.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
15.6.1. Gulf Cooperation Council (GCC) Countries
15.6.2. Israel
15.6.3. South Africa
15.6.4. Rest of MEA
15.7. MEA Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country, 2022 – 2028
15.8. MEA Infectious Disease Diagnostics Market Dynamics – Trends
16. Competition Landscape 
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Testing Types, Key Developments, Strategies, and SWOT Analysis)
16.2.1. Abbott Laboratories
16.2.2. Becton Dickinson and Company
16.2.3. bioMerieus SA
16.2.4. Bio-Rad Laboratories
16.2.5. Danaher Corporation
16.2.6. F Hoffman-La Roche
16.2.7. Hologic Inc.
16.2.8. Luminex Corporation
16.2.9. Qiagen Inc.
16.2.10. Thermo Fisher Scientific Inc.
16.2.11. LumiraDx
17. Research Methodology
18. Key Assumptions and Acronyms
Report

Company Profile

  • Abbott Laboratories
  • Becton Dickinson and Company
  • BioMerieus SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F Hoffman-La Roche
  • Hologic Inc.
  • Luminex Corporation
  • Qiagen Inc
  • Thermo Fisher Scientific Inc.
  • LumiraDx

Description

Infectious Disease Diagnostics Market size is expected to be worth USD 34,599.0 million in 2020, growing at a high CAGR of 6.4% from 2022 to 2028 to reach USD 50,201.2 million by 2028. The market for infectious disease diagnostics is fueled by increased infectious disease prevalence, a shift in focus from centralized laboratories to decentralized point-of-care testing, and Infectious Disease Research Diagnostics, increased prevalence of infectious disease, increased number of medical laboratories for infectious disease diagnostic testing, increased demand for point-of-care diagnostic tests, increased funding from private and government organizations for diagnostic service centers, and advancements in infectious disease diagnostic technologies. Infectious diseases are illnesses brought on by bacteria, viruses, fungi, or parasites. In most cases, they’re innocuous or even beneficial. However, some microbes can cause sickness under particular circumstances. Some infectious diseases are contagious and can be spread from one person to the next. The technique by which the causative agent of an infectious disease is discovered and often defined is known as infectious-disease diagnostics. However, inadequate reimbursements and rising healthcare costs limiting the use of novel diagnostic techniques hampers the Infectious Disease Diagnostics market.

Key Developments:

In February 2021, Thermo Fisher Scientific acquired Mesa Biotech (US) to expand the benefits of molecular diagnostics at the point of care.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX

QUICKLINKS
RESEARCH AREAS
PRESS RELEASE
CONTACT US
+1-866-598-1553
EMAIL
sales@precisionbusinessinsights.com
FOLLOW US
QUICK LINKS+
RESEARCH AREAS+
PRESS RELEASE+
CONTACT US+
+1-866-598-1553
sales@precisionbusinessinsights.com
FOLLOW US AT+